Eli Lilly launches anti-obesity drug Zepbound with one-month dosage
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York on March 28, 2024.…
Novo Nordisk A/S
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…
FDA Chief Marty Makary on GLP-1 Copies, Vaccines and China
U.S. Food and Drug Administration (FDA) Commissioner Marty Makary presents a study from The Lancet during an announcement of the…
Medicare coverage opens opportunity for 15 million patients
Nordisk Chief Executive Mike Doustdar said Wednesday that the company aims to recruit about 15 million new patients, at least…
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Nordisk on Monday said he is suing an online telehealth provider him and her to mass market cheaper, unapproved copies…
FDA Says Novo Nordisk Anti-Obesity Pill TV Ad Includes Misleading Claims
Still life of the new Wegovy semaglutide tablets on a white background. It is a prescription medication used with a…
Hims & Hers pulls knockoff weight-loss pill after legal threats
Piotr Swat | Light rocket | fake images him and her on Saturday said it will pull its knock-off weight-loss…
Eli Lilly (LLY) Earnings in Q4 2025
Eli Lilly on Wednesday released fourth-quarter earnings, revenue and 2026 guidance that beat estimates, as demand soars for its blockbuster…
White House launches direct-to-consumer drug site
President Donald Trump makes an announcement from the Oval Office of the White House in Washington, November 6, 2025. Jonathan…
Eli Lilly Wins in LPG-1 Market Over Novo Nordisk, Earnings Show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Little Tom | Reuters It's the story of two drugmakers…